Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome

Leukemia Research

Volumn 33, Issue 1, 2009, Pages 88-99

  Steinhoff, Matthias ^a   Schöpp, Sebastian ^a   Assaf, Chalid ^a   Muche, Marcus ^a   Beyer, Marc ^a   Sterry, Wolfram ^a   Lukowsky, Ansgar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD26; CD7; Quantitative PCR; S zary syndrome; T cell receptor PCR

Indexed keywords

CD7 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEZARY SYNDROME; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD26; ANTIGENS, CD7; BASE SEQUENCE; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; SEZARY SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 55049131602     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.025     Document Type: Article

References (35)

1. Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
2. Lutzner M.A., and Jordan H.W. The utrastructure of an abnormal cell in Sézary's syndrome. Blood 31 (1968) 719-726
3. Duncan S.C., and Winkelmann R.K. Circulating Sézary cells in hospitalized dermatology patients. Br J Dermatol 99 (1978) 171-178
4. van der Loo E.M., Cnossen J., and Meijer C.J.L.M. Morphological aspects of T-cell subpopulations in human blood: characterization of the cerebriform mononuclear cells in healthy individuals. Clin Exp Immunol 43 (1981) 506-516
5. Vonderheid E.C., Bernengo M.G., Burg G., et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46 (2002) 96-106
6. Laroche L., and Bach J.-F. T cell imbalance in nonleukemic and leukemic cutaneous lymphoma defined by monoclonal antibodies. Clin Immunol Immunopathol 20 (1981) 278-284
7. Waldmann T.A., Greene W.C., Sarin P.S., et al. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. J Clin Invest 73 (1984) 1711-1718
8. Bernengo M.G., Quaglino P., Novell M., et al. Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol 9 (1998) 857-863
9. Washington L.T., Huh Y.O., Powers L.C., et al. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2 (2002) 5-12
10. Edelman J., and Meyerson H.J. Diminished CD3 expression is useful for detecting and enumerating Sezary cells. Am J Clin Pathol 114 (2000) 345-352
11. Bogen S.A., Pelley D., Charif M., et al. Immunophenotypic identification of Sezary cells in peripheral blood. Am J Clin Pathol 106 (1996) 739-748
12. Harmon C.B., Witzig T.E., Katzmann J.A., et al. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol 35 (1996) 404-410
13. Scala E., Russo G., Cadoni S., et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J Invest Dermatol 113 (1999) 622-627
14. Bernengo M.G., Novelli M., Quaglino P., et al. The relevance of the CD4+CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 144 (2001) 125-135
15. Jones D., Dang N.H., Duvic M., et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115 (2001) 885-892
16. Vonderheid E.C. On the diagnosis of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol 33 1 (2006) 27-42
17. Kim Y., Bishop K., Varghese A., and Hoppe R.T. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 131 (1995) 1003-1008
18. Vonderheid E.C., and Bernengo M.G. The Sezary syndrome: hematologic criteria. Hematol Oncol Clin North Am 17 (2003) 1367-1389
19. Laetsch B., Haffner A.C., Dobbeling U., et al. CD4+/CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol 114 (2000) 107-111
20. Olsen E., Vonderheid E., Pimpinelli N., et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society of Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 (2007) 1713-1722
21. Dummer R., Nestle F.O., Niederer E., et al. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res 291 (1999) 307-311
22. Muche J.M., Lukowsky A., Asadullah K., Gellrich S., and Sterry W. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 90 (1997) 1636-1642
23. Moss P., Charmley P., Mulvihill E., et al. The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. J Invest Dermatol 109 (1997) 14-19
24. Kneba M., Bolz I., Linke B., and Hiddemann W. Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 86 (1995) 3930-3937
25. Jakob T., Neuber K., Altenhoff J., Kowalzick L., and Ring J. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma. Acta Dermatol Venereol 76 (1996) 34-36
26. Vonderheid E.C., Bigler R.D., Kotecha A., et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome). J Invest Dermatol 117 (2001) 654-662
27. Wood G.S., Hong S.R., Sasaki D.T., et al. Leu-8/CD7 antigen expression of CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol 22 (1990) 602-607
28. Russell-Jones R. Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 153 (2005) 1-5
29. Abel E.A., Lindae M.L., Hoppe R.T., and Wood G. Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics. J Am Acad Dermatol 9 (1988) 1089-1095
30. Yawalkar N., Hunger R.E., Pichler W.J., Braathen L.R., and Brand C.U. Human afferent lymph from normal skin contains an increased number of mainly memory/effector CD4(+) T cells expressing activation, adhesion and co-stimulatory molecules. Eur J Immunol 30 (2000) 491-497
31. Rappl G., Muche J.M., Abken H., et al. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome. J Am Acad Dermatol 44 (2001) 456-461
32. Vowels B.R., Cassin M., Vonderheid E.C., and Rook A.H. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99 (1992) 90-94
33. Kari L., Loboda A., Kari L., et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 197 (2003) 1477-1488
34. Wysocka M., Zaki M.H., French L.E., et al. Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 100 (2002) 3287-3294
35. Willheim M., Ebner C., Baier K., et al. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol 100 (1997) 348-355